The U.S. has granted Austrian firm Intercell approval for its Ixiaro vaccine to protect pediatric patients against Japanese encephalitis.
Intercell gains OK for Japanese encephalitis vaccine in children
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management